Hartmut Kirchner

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

Norbert Schmitz, Beate Pfistner, M. Sextro et al. · The Lancet · 2002 · 1.1K citations

Medicine, Clinical Sciences, Oncology +13

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

Andreas Engert, Annette Plütschow, Hans Theodor Eich et al. · New England Journal of Medicine · 2010 · 921 citations · Full text

Medicine, Oncology, Chemotherapy +8

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

Ulrich Schwab, Harald Stein, Johannes Gerdes et al. · Nature · 1982 · 873 citations

Medicine, Hematology, Pathology +10

Incidence and Prognostic Influence of <i>DNMT3A</i> Mutations in Acute Myeloid Leukemia

Felicitas Thol, Frédérik Damm, Andrea Lüdeking et al. · Journal of Clinical Oncology · 2011 · 376 citations · Full text

Medicine, Hematology, Molecular Genetics +17

Impact of <i>IDH1</i> R132 Mutations and an <i>IDH1</i> Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor

Katharina Wagner, Frédérik Damm, Gudrun Göhring et al. · Journal of Clinical Oncology · 2010 · 240 citations

Life Sciences, Genetics, Molecular Genetics +16